MPN Alliance Australia Newsletter
Momelotinib for anaemic myelofibrosis?
The Pharmaceutical Benefits Advisory Committee is considering whether to include Momelotinib onto the Pharmaceutical Benefits Scheme. It is open for comments until 25 September.
See HERE for more information.